The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Delivery strategies for sustained drug release in the lungs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Aerosol Technology Properties, Behavior, and Measurement of Airborne Particles
LAUCKS, M. L. (2000) · Journal of Aerosol Science · doi:10.1016/s0021-8502(99)00571-6 · Cited by 3,367
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Poly(ethylene glycol) chemistry : biotechnical and biomedical applications
Harris, J. M. (1992) · Plenum Press eBooks · Cited by 1,426
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,331
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,286
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Labiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,245
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Deposition of particles in the human respiratory tract in the size range 0.005–15 μm
Heyder, J., Gebhart, J., Rudolf, G., Schiller, C. F., & Stahlhofen, W. (1986) · Journal of Aerosol Science · doi:10.1016/0021-8502(86)90035-2 · Cited by 1,026
Pegylation: A Novel Process for Modifying Pharmacokinetics
Harris, J. M., Martin, N. E., & Modi, M. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00005 · Cited by 913
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Particle Engineering for Pulmonary Drug Delivery
Chow, A. H. L., Tong, H. H. Y., Chattopadhyay, P., & Shekunov, B. Y. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9174-3 · Cited by 645
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Regional Lung Deposition and Bronchodilator Response as a Function of β 2 -Agonist Particle Size
Usmani, O. S., Biddiscombe, M. F., & Barnes, P. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1414oc · Cited by 578
Weber, S., Zimmer, A., & Pardeike, J. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.013 · Cited by 568
The Lungs as a Portal of Entry for Systemic Drug Delivery
Patton, J. S., Fishburn, C. S., & Weers, J. G. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-049ta · Cited by 563
Trojan particles: Large porous carriers of nanoparticles for drug delivery
Tsapis, N., Bennett, D., Jackson, B., Weitz, D. A., & Edwards, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182233999 · Cited by 546
Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening
Yeh, T.-H., Hsu, L.-W., Tseng, M. T., Lee, P.-L., Sonjae, K., Ho, Y.-C., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.056 · Cited by 379
Möller, W., Felten, K., Sommerer, K., Scheuch, G., Meyer, G., Meyer, P., Häussinger, K., & Kreyling, W. G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-301oc · Cited by 364
Meers, P., Neville, M., Malinin, V., Scotto, A. W., Sardaryan, G., Kurumunda, R., Mackinson, C., James, G., Fisher, S., & Perkins, W. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn059 · Cited by 345
Mignani, S., El Kazzouli, S., Bousmina, M., & Majoral, J.-P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.001 · Cited by 335
Formulation and Physical Characterization of Large Porous Particles for Inhalation
Vanbever, R., Mintzes, J. D., Wang, J., Nice, J., Chen, D., Batycky, R., Langer, R., & Edwards, D. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1018910200420 · Cited by 314
Self-citationDevelopment of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
Geller, D. E., Weers, J., & Heuerding, S. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0855 · Cited by 308
Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems
Bibby, D. C., Davies, N. M., & Tucker, I. G. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00335-5 · Cited by 298
Ungaro, F., d'Angelo, I., Coletta, C., d'Emmanuele di Villa Bianca, R., Sorrentino, R., Perfetto, B., Tufano, M. A., Miro, A., La Rotonda, M. I., & Quaglia, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.010 · Cited by 297
Semmler-Behnke, M., Takenaka, S., Fertsch, S., Wenk, A., Seitz, J., Mayer, P., Oberdörster, G., & Kreyling, W. G. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9685 · Cited by 262
Serisier, D. J., Bilton, D., De Soyza, A., Thompson, P. J., Kolbe, J., Greville, H. W., Cipolla, D., Bruinenberg, P., Gonda, I., & the ORBIT-2 investigators (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203207 · Cited by 250
Solid lipid nanoparticles for pulmonary delivery of insulin
Liu, J., Gong, T., Fu, H., Wang, C., Wang, X., Chen, Q., Zhang, Q., He, Q., & Zhang, Z. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.008 · Cited by 248
Crowder, T. M., Rosati, J. A., Schroeter, J. D., Hickey, A. J., & Martonen, T. B. (2002) · Pharmaceutical Research · doi:10.1023/a:1014426530935 · Cited by 247
The Role of Macrophages in the Clearance of Inhaled Ultrafine Titanium Dioxide Particles
Geiser, M., Casaulta, M., Kupferschmid, B., Schulz, H., Semmler-Behnke, M., & Kreyling, W. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0138oc · Cited by 242
PEGylated Protein Drugs: Basic Science and Clinical Applications
(2009) · doi:10.1007/978-3-7643-8679-5 · Cited by 241
Dry powders for oral inhalation free of lactose carrier particles
Healy, A. M., Amaro, M. I., Paluch, K. J., & Tajber, L. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.005 · Cited by 234
Extracellular barriers in respiratory gene therapy
Sanders, N., Rudolph, C., Braeckmans, K., De Smedt, S. C., & Demeester, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.011 · Cited by 229
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
Clancy, J. P., Dupont, L., Konstan, M. W., Billings, J., Fustik, S., Goss, C. H., Lymp, J., Minic, P., Quittner, A. L., Rubenstein, R. C., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202230 · Cited by 222
Dailey, L. A., Jekel, N., Fink, L., Gessler, T., Schmehl, T., Wittmar, M., Kissel, T., & Seeger, W. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.016 · Cited by 220
Controlled pulmonary drug and gene delivery using polymeric nano-carriers
Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.004 · Cited by 200
Kaminskas, L. M., McLeod, V. M., Ryan, G. M., Kelly, B. D., Haynes, J. M., Williamson, M., Thienthong, N., Owen, D. J., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.012 · Cited by 190
Emerging inhalation aerosol devices and strategies: Where are we headed?
Zhou, Q. (., Tang, P., Leung, S. S. Y., Chan, J. G. Y., & Chan, H.-K. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.006 · Cited by 188
Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises
Ungaro, F., d' Angelo, I., Miro, A., La Rotonda, M. I., & Quaglia, F. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01486.x · Cited by 183
Dailey, L. A., Schmehl, T., Gessler, T., Wittmar, M., Grimminger, F., Seeger, W., & Kissel, T. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00370-x · Cited by 180
Fee, C. J., & Van Alstine, J. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049843w · Cited by 174
Gill, K. K., Nazzal, S., & Kaddoumi, A. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.017 · Cited by 173
Nassimi, M., Schleh, C., Lauenstein, H. D., Hussein, R., Hoymann, H. G., Koch, W., Pohlmann, G., Krug, N., Sewald, K., Rittinghausen, S., et al. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.014 · Cited by 173
Ungaro, F., d'Emmanuele di Villa Bianca, R., Giovino, C., Miro, A., Sorrentino, R., Quaglia, F., & La Rotonda, M. I. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.011 · Cited by 167
Garbuzenko, O. B., Saad, M., Betigeri, S., Zhang, M., Vetcher, A. A., Soldatenkov, V. A., Reimer, D. C., Pozharov, V. P., & Minko, T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9755-4 · Cited by 167
New polymeric carriers for controlled drug delivery following inhalation or injection
Fu, J., Fiegel, J., Krauland, E., & Hanes, J. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00182-5 · Cited by 163
Colloidal soft matter as drug delivery system
Bonacucina, G., Cespi, M., Misici‐Falzi, M., & Palmieri, G. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21423 · Cited by 160
Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery
Willis, L., Hayes, D., & Mansour, H. M. (2012) · Lung · doi:10.1007/s00408-011-9360-x · Cited by 148
Drug transporters in the lung—do they play a role in the biopharmaceutics of inhaled drugs?
Bosquillon, C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21995 · Cited by 148
Safety of Poly(ethylene glycol) and Poly(ethylene glycol) Derivatives
Working, P. K., Newman, M. S., Johnson, J. A., & Cornacoff, J. B. (1997) · ACS symposium series · doi:10.1021/bk-1997-0680.ch004 · Cited by 139
Nanodelivery in airway diseases: Challenges and therapeutic applications
Roy, I., & Vij, N. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.07.001 · Cited by 137
Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluation
Rawat, A., Majumder, Q. H., & Ahsan, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.013 · Cited by 136
Pulmonary Delivery of Free and Liposomal Insulin
Liu, F., Shao, Z., Kildsig, D. O., & Mitra, A. K. (1993) · Pharmaceutical Research · doi:10.1023/a:1018934810512 · Cited by 134
Fate of nanomedicines in the lungs
Todoroff, J., & Rita Vanbever, A. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2011.03.001 · Cited by 129
Self-citationAlveolar macrophages are a primary barrier to pulmonary absorption of macromolecules
Lombry, C., Edwards, D. A., Véronique Préat, A., & Rita Vanbever, A. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00260.2003 · Cited by 126
How the Lung Handles Drugs: Pharmacokinetics and Pharmacodynamics of Inhaled Corticosteroids
Winkler, J., Hochhaus, G., & Derendorf, H. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200403-025ms · Cited by 122
Hitzman, C. J., Elmquist, W. F., Wattenberg, L. W., & Wiedmann, T. S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20591 · Cited by 119
Ryan, G. M., Kaminskas, L. M., Kelly, B. D., Owen, D. J., McIntosh, M. P., & Porter, C. J. H. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400091n · Cited by 119
Oh, Y. J., Lee, J., Seo, J. Y., Rhim, T., Kim, S., Yoon, H. J., & Lee, K. Y. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.001 · Cited by 118
Size-Dependent Dextran Transport across Rat Alveolar Epithelial Cell Monolayers
Matsukawa, Y., Lee, V. H. L., Crandall, E. D., & Kim, K.-J. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960352x · Cited by 114
Characterization of Nebulized Liposomal Amikacin (Arikace ™ ) as a Function of Droplet Size
Li, Z., Zhang, Y., Wurtz, W., Lee, J. K., Malinin, V., Durwas-Krishnan, S., Meers, P. R., & Perkins, W. R. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0686 · Cited by 112
The Effect of Lung Structure on Mucociliary Clearance and Particle Retention in Human and Rat Lungs
Hofmann, W. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg075 · Cited by 111
Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery
Ruchang, B., Shao, W., Wang, Q., & Zhang, N. (2008) · Journal of drug targeting · doi:10.1080/10611860802201134 · Cited by 108
Jebria, A. B., Chen, D., Eskew, M. L., Rita Vanbever, A., Langer, R., & Edwards, D. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1018879331061 · Cited by 104
Li, Y., Sun, X., Gong, T., Liu, J., Zuo, J., & Zhang, Z. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0201-z · Cited by 103
Chougule, M. B., Padhi, B. K., & Misra, A. R. (2007) · PubMed Central · Cited by 97
Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery
Yang, Z., Chen, X., Huang, W., Wong, B. C. K., Yin, L., Wong, I. Y. F., & Xu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28011 · Cited by 97
Bai, S., & Ahsan, F. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9769-y · Cited by 95
Xie, Y., Aillon, K. L., Cai, S., Christian, J. M., Davies, N. M., Berkland, C. J., & Forrest, M. L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.058 · Cited by 93
Swellable microparticles as carriers for sustained pulmonary drug delivery
El-sherbiny, I. M., McGill, S. L., & Smyth, H. D. C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22003 · Cited by 92
Inapagolla, R., Guru, B. R., Kurtoglu, Y. E., Gao, X., Lieh-Lai, M. W., Bassett, D. J. P., & Kannan, R. M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.030 · Cited by 85
Koussoroplis, S. J., Paulissen, G., Tyteca, D., Goldansaz, H., Todoroff, J., Barilly, C., Uyttenhove, C., Snick, J. V., Cataldo, D. D., & Rita Vanbever, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.021 · Cited by 85
Self-citationMurata, M., Nakano, K., Tahara, K., Tozuka, Y., & Takeuchi, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.011 · Cited by 84
Quercetin solid lipid microparticles: A flavonoid for inhalation lung delivery
Scalia, S., Haghi, M., Losi, V., Trotta, V., Young, P. M., & Traini, D. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.03.009 · Cited by 80
Rosa, G. D., Larobina, D., Rotonda, M. I. L., Musto, P., Quaglia, F., & Ungaro, F. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.030 · Cited by 79
Chimote, G., & Banerjee, R. (2010) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31608 · Cited by 79
Niven, R. W., Whitcomb, K. L., Shaner, L., Ip, A. Y., & Kinstler, O. B. (1995) · Pharmaceutical Research · doi:10.1023/a:1016281925554 · Cited by 77
Youn, Y. S., Kwon, M. J., Na, D. H., Chae, S. Y., Lee, S., & Lee, K. C. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.008 · Cited by 74
The Use of Human Deoxyribonuclease (rhDNase) in the Management of Cystic Fibrosis
Suri, R. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00001 · Cited by 73
Inhalable liposomal formulation for vasoactive intestinal peptide
Hajos, F., Stark, B., Hensler, S., Prassl, R., & Mosgoeller, W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.046 · Cited by 64
Tolman, J. A., & Williams, R. O. (2009) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903092319 · Cited by 64
Youn, Y. S., Choi, J. S., Lee, C., Kim, I.-S., Oh, K. T., Lee, Lee, K. C., & Park, E. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s48197 · Cited by 63
Zinc–alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying
Moebus, K., Siepmann, J., & Bodmeier, R. A. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.01.018 · Cited by 63
Gupta, V., & Ahsan, F. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.017 · Cited by 60
Sustained release of insulin from insoluble inhaled particles
Rita Vanbever, A., Jebria, A. B., Mintzes, J. D., Langer, R., & Edwards, D. A. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199912)48:4<178::aid-ddr5>3.0.co;2-i · Cited by 56
Dhanda, D. S., Tyagi, P., Mirvish, S. S., & Kompella, U. B. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.027 · Cited by 56
Magnetised Thermo Responsive Lipid Vehicles for Targeted and Controlled Lung Drug Delivery
Upadhyay, D., Scalia, S., Vogel, R., Wheate, N., Salama, R., Young, P. M., Traini, D., & Chrzanowski, W. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0774-9 · Cited by 52
Regional lung deposition of nebulized liposome-encapsulated ciprofloxacin
Finlay, W. H., & Wong, J. P. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00055-6 · Cited by 51
Watanabe, M., Okada, M., Kudo, Y., Tonori, Y., Niitsuya, M., Satō, T., Aizawa, Y., & Kotani, M. (2002) · Journal of Toxicology and Environmental Health · doi:10.1080/152873902760125219 · Cited by 49
Tawfeek, H. M., Khidr, S. H., Samy, E. M., Ahmed, S. M., Murphy, M. F., Mohammed, A. R., Shabir, A., Hutcheon, G. A., & Saleem, I. Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0433-6 · Cited by 46
Lee, K. C., Chae, S. Y., Kim, T. H., Lee, S., Lee, E. S., & Youn, Y. S. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.09.008 · Cited by 42
Polyethylene glycol-drug ester conjugates for prolonged retention of small inhaled drugs in the lung
Bayard, F. J. C., Thielemans, W., Pritchard, D., Paine, S. W., Young, S. S., Bäckman, P., Ewing, P., & Bosquillon, C. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.023 · Cited by 42
Aljayyoussi, G., Price, D. F., Francombe, D., Taylor, G., Smith, M. W., Morris, C., Edwards, C. D., Eddershaw, P. J., & Gumbleton, M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23587 · Cited by 38
Beck‐Broichsitter, M., Rieger, M., Reul, R., Gessler, T., Seeger, W., & Schmehl, T. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.12.003 · Cited by 37
Gibbons, A., McElvaney, N. G., & Cryan, S. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9500-2 · Cited by 35
Todoroff, J., Učakar, B., Inglese, M., Vandermarliere, S., Fillée, C., Renauld, J., Huygen, K., & Rita Vanbever, A. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.020 · Cited by 31
Self-citationBaginski, L., Tachon, G., Falson, F., Patton, J. S., Bakowsky, U., & Ehrhardt, C. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0842 · Cited by 30
Development of Liposomal Salbutamol Sulfate Dry Powder Inhaler Formulation
Huang, W., Yang, Z., Wu, H., Wong, Y.-F., Zhao, Z., & Liu, L. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.512 · Cited by 26
Experimental pulmonary delivery of cyclosporin A by liposome aerosol
Waldrep, J. C., Arppe, J., Jansa, K., & Vidgren, M. T. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00322-0 · Cited by 25
Doan, T. V. P., Grégoire, N., Lamarche, I., Gobin, P., Marchand, S., Couet, W. R., & Olivier, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.024 · Cited by 21
Sahib, M. N., Darwis, Y., Peh, K. K., Abdulameer, S. A., & Tan, Y. T. F. (2012) · Drug Development Research · doi:10.1002/ddr.21000 · Cited by 20
Niven, R. W., Whitcomb, K. L., Shaner, L., Ralph, L. D., Habberfield, A. D., & Wilson, J. V. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90056-6 · Cited by 20
Nakanishi, T., Hasegawa, Y., Haruta, T., Wakayama, T., & Tamai, I. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23603 · Cited by 18
Cited by
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Microfluidic fabrication of microparticles for biomedical applications
Li, W., Zhang, L., Ge, X., Xu, B., Zhang, W., Qu, L., Choi, C.-H., Xu, J., Zhang, A., Lee, H., et al. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00263g · Cited by 585
Duan, C., Yu, M., Xu, J., Li, B.-Y., Zhao, Y., & Kankala, R. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114643 · Cited by 335
Current Status of Alginate in Drug Delivery
Hariyadi, D. M., & Islam, N. (2020) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2020/8886095 · Cited by 272
Banerjee, A., Pathak, S., Subramanium, V. D., G., D., Murugesan, R., & Verma, R. S. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.006 · Cited by 204
Metadata
- Authors
- Loira-Pastoriza, C., Todoroff, J., & Vanbever, R.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 75
- Pages
- 81-91
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1998867182
- Cited by
- 393
- References
- 106
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.